(Q42505242)

1 November 2017

title

Topical photodynamic therapy at low fluence rates--theory and practice (English)

1 reference

1 November 2017

Langmack K

1

1 reference

1 November 2017

Mehta R

series ordinal

2

1 reference

1 November 2017

Twyman P

series ordinal

3

1 reference

1 November 2017

Norris P

series ordinal

4

1 reference

1 November 2017

publication date

1 April 2001

1 reference

Journal of Photochemistry and Photobiology B

1 November 2017

published in

1 reference

1 November 2017

volume

60

1 reference

1 November 2017

issue

1

1 reference

1 November 2017

page(s)

37-43

1 reference

Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2801%2900116-6

7 January 2021

The importance of fluence rate in photodynamic therapy: is there a parallel with ionizing radiation dose-rate effects?

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2801%2900116-6

7 January 2021

Enhanced effectiveness of photodynamic therapy with laser light fractionation in patients with esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2801%2900116-6

7 January 2021

Enhanced photodynamic effects using fractionated laser light

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2801%2900116-6

7 January 2021

Oxygen consumption and diffusion effects in photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2801%2900116-6

7 January 2021

In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2801%2900116-6

7 January 2021

Oxygen consumption through metabolism and photodynamic reactions in cells cultured on microbeads

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2801%2900116-6

7 January 2021

Quantum yields and kinetics of the photobleaching of hematoporphyrin, Photofrin II, tetra(4-sulfonatophenyl)-porphine and uroporphyrin

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2801%2900116-6

7 January 2021

The mechanism of Photofrin photobleaching and its consequences for photodynamic dosimetry

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2801%2900116-6

7 January 2021

PDT light dosimetry revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2801%2900116-6

7 January 2021

Dosimetry model for photodynamic therapy with topically administered photosensitizers

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2801%2900116-6

7 January 2021

Dosimetry in photodynamic therapy: oxygen and the critical importance of capillary density

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2801%2900116-6

7 January 2021

A transient mathematical model of oxygen depletion during photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2801%2900116-6

7 January 2021

A theoretical study of light fractionation and dose-rate effects in photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2801%2900116-6

7 January 2021

Predictions of mathematical models of tissue oxygenation and generation of singlet oxygen during photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2801%2900116-6

7 January 2021

Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2801%2900116-6

7 January 2021

Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas?

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2801%2900116-6

7 January 2021

Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2801%2900116-6

7 January 2021

Long-pulse dye laser for photodynamic therapy: investigations in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2801%2900116-6

7 January 2021

Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2801%2900116-6

7 January 2021

Photodynamic therapy in dermatology

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2801%2900116-6

7 January 2021

Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2801%2900116-6

7 January 2021

10.1016/S1011-1344(01)00116-6

Identifiers

DOI

1 reference

1 November 2017

1 reference